Skip to content

Cryo-nerve blockade for perioperative pain relief during sternotomy in cardiac surgery

Cryo-nerve blockade for perioperative pain relief during sternotomy in cardiac surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00037234
Enrollment
100
Registered
2025-10-13
Start date
2025-11-20
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

perioperative pain, sternotomy, cryo-nerve blockade

Interventions

Group 1: 50 patients receiving sternotomy with painkiller treatment and cryo-nerve blockade Group 2: control group 50 patients receiving sternotomy with painkiller treatment but without cryo-nerve blo

Sponsors

Justus Liebig Universität Gießen
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: all-comers patients undergoing coronary bypass and / or aortic valve procedures via full sternotomy

Exclusion criteria

Exclusion criteria: Patients younger than 18 years Patients with thoracic or pectoral malformations (i.e. pectus excavatum, kyphosis) Patients with known painkiller abuse or opioid abuse Patients with painkiller allergies Patients with combination procedures Patients unable to give informed written consent Patients with contraindications to painbuster intake Patients unable to take part in telephone follow ups Patients with lactation or pregnancy Patients with COPD Gold III or IV

Design outcomes

Primary

MeasureTime frame
-Pain-symptoms: standardized pain quantification at baseline and during the follow-up visits (e.g., at day -1, pod1-10, pod30, pod90 and pod180) using a paper-based format on the visual analogue scale -Pain-killer-consumption (measured and documented prospectively; opioid consumption is measured in milligrams of oral morphine equivalents and daily use of non-opioid painkillers is recorded) -Signs of discomfort due to hypoaesthesia using a standardized discomfort quantification at baseline and during the follow-up visits (e.g., at day -1, pod1-10, pod30, pod90 and pod180) using a paper-based format

Secondary

MeasureTime frame
-Therapeutic safety -Physical and psychological rehabilitation (SF 12 questionnaires before the intervention (at baseline) and during the follow-up visits (e.g., at pod 10, pod30, pod90 and pod180)) -quality of life (EuroQol 5D-5L questionnaires) before the intervention (at baseline) and during the follow-up visits (e.g., at 7 days, 30 days) -perioperative morbidity (MACCE, bleeding, wound healing disorders, re-operation, length of ventilation, length of ICU-stay, gastrointestinal disorders, blood-cell-count- disorders) -delirium (preoperative scanning and postoperative questionnaire at each postoperative day up to pod10) “Confusion Assessment Method for the ICU (CAM ICU)" -effects on transitional pain -effects on chronic pain

Countries

Germany

Contacts

Public ContactBernd Niemann

Justus Liebig Universität Gießen

bernd.niemann@chiru.med.uni-giessen.de0641-985 44301

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 7, 2026